Education
About Us
Working with TipRanks
Follow Us
China Resources Pharmaceutical Group Ltd. (DE:640)
FRANKFURT:640
640 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.53 - €0.84
Previous CloseN/A
Volume0.00
Average Volume (3M)100.00
Market Cap
€3.45B
Enterprise Value€155.27B
Total Cash (Recent Filing)HK$16.63B
Total Debt (Recent Filing)HK$50.94B
Price to Earnings (P/E)7.7
Beta0.43
Next Earnings
Aug 21, 2025EPS Estimate
0.05Next Dividend Ex-Date
May 28, 2025Dividend Yield5.87%
Share Statistics
EPS (TTM)0.07
Shares Outstanding6,282,510,300
10 Day Avg. Volume0
30 Day Avg. Volume100
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.17
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€0.69Price Target Upside32.69% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
---
China Resources Pharmaceutical Group Ltd. News
PremiumCompany Announcements
China Resources Pharmaceutical Completes Acquisition of Tasly Stake
PremiumCompany Announcements
China Resources Pharmaceutical Group Announces Final Dividend for 2024
PremiumCompany Announcements
China Resources Pharmaceutical Reports Revenue and Profit Growth for 2024
PremiumCompany Announcements
CR Double-Crane Reports 2024 Financial Results with Dividend Proposal
PremiumCompany Announcements
CR Boya Bio-pharmaceutical Reports 2024 Financial Results
PremiumCompany Announcements
Dong-E-E-Jiao Reports Strong Financial Growth for 2024---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.52%
Mutual Funds
― Other Institutional Investors
95.86% Public Companies and
Individual Investors
640 FAQ
What was China Resources Pharmaceutical Group Ltd.’s price range in the past 12 months?
China Resources Pharmaceutical Group Ltd. lowest stock price was €0.53 and its highest was €0.83 in the past 12 months.
What is China Resources Pharmaceutical Group Ltd.’s market cap?
China Resources Pharmaceutical Group Ltd.’s market cap is €3.45B.
When is China Resources Pharmaceutical Group Ltd.’s upcoming earnings report date?
China Resources Pharmaceutical Group Ltd.’s upcoming earnings report date is Aug 21, 2025 which is in 133 days.
How were China Resources Pharmaceutical Group Ltd.’s earnings last quarter?
China Resources Pharmaceutical Group Ltd. released its earnings results on Mar 26, 2025. The company reported €0.014 earnings per share for the quarter, missing the consensus estimate of €0.027 by -€0.013.
Is China Resources Pharmaceutical Group Ltd. overvalued?
According to Wall Street analysts China Resources Pharmaceutical Group Ltd.’s price is currently Undervalued.
Does China Resources Pharmaceutical Group Ltd. pay dividends?
China Resources Pharmaceutical Group Ltd. pays a Annually dividend of €0.007 which represents an annual dividend yield of 5.87%. See more information on China Resources Pharmaceutical Group Ltd. dividends here
What is China Resources Pharmaceutical Group Ltd.’s EPS estimate?
China Resources Pharmaceutical Group Ltd.’s EPS estimate is 0.05.
How many shares outstanding does China Resources Pharmaceutical Group Ltd. have?
China Resources Pharmaceutical Group Ltd. has 6,282,510,300 shares outstanding.
What happened to China Resources Pharmaceutical Group Ltd.’s price movement after its last earnings report?
China Resources Pharmaceutical Group Ltd. reported an EPS of €0.014 in its last earnings report, missing expectations of €0.027. Following the earnings report the stock price went down -6.25%.
Which hedge fund is a major shareholder of China Resources Pharmaceutical Group Ltd.?
Currently, no hedge funds are holding shares in DE:640
---
China Resources Pharmaceutical Group Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€0.69 (32.69% Upside)
€0.69 (32.69% Upside)
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
―
20 days / 200 days
Momentum
1.15%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
7.22%
Trailing 12-Months
Company Description
China Resources Pharmaceutical Group Ltd.
CR Pharma, is a vertically integrated conglomerate that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the third largest drug distributor by revenue, with a strong presence in Eastern, Northern, and Southern China. Its drug manufacturing segment primarily consists of four listed subsidiaries, Dong E E Jiao, CR Sanjiu, CR Double Crane, and Jiangzhong Pharmaceutical, which are well-known makers of over-the-counter traditional Chinese medicines (or TCM), health supplements, and prescription drugs. The company's estimated operating income is approximately 56% distribution, 43% manufacturing, and less than 1% retail pharmacies.
---
640 Stock 12 Month Forecast
Average Price Target
€0.69
▲(32.69% Upside)
Technical Analysis
Sino Biopharmaceutical
―
CSPC Pharmaceutical Group
―
Livzon Pharmaceutical Group
―
Pacific Basin Shipping
―
Shanghai Pharmaceuticals Holding Co
―
Best Analysts Covering 640
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
+5.97%
reiterated a buy rating 7 months ago
Copying Laurence Tam's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +5.97% per trade.
---